Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CRMD
CRMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRMD News
CorMedix to Present at Upcoming Investor Conferences
3d ago
Newsfilter
CorMedix's Near-Term Growth Prospects Analysis
4d ago
Yahoo Finance
CorMedix Approves $75M Share Repurchase Program
Feb 02 2026
seekingalpha
CorMedix Approves $75 Million Share Repurchase Program
Feb 02 2026
Newsfilter
CorMedix to Present Corporate Overview at 44th J.P. Morgan Healthcare Conference
Jan 09 2026
Globenewswire
CorMedix and GM See Significant Options Trading Volume Surge
Jan 08 2026
NASDAQ.COM
U.S. Initial Jobless Claims Rise to 208,000, Mixed Market Reaction
Jan 08 2026
Benzinga
Acuity Inc. Reports 20.2% Revenue Growth in Q1 2026
Jan 08 2026
Benzinga
Exelixis Collaborates with Natera for STELLAR-316 CRC Study
Jan 08 2026
NASDAQ.COM
CorMedix Appoints New Executive, CEO Joseph Todisco Takes Chairman Role
Jan 08 2026
Globenewswire
AstraZeneca Secures FDA Approval for Enhertu in First-Line Breast Cancer, Triggers $150M Milestone Payment
Dec 23 2025
NASDAQ.COM
Novo Nordisk Submits NDA for Advanced Obesity Treatment CagriSema
Dec 19 2025
NASDAQ.COM
CorMedix Reports Interim Results Showing 72% Reduction in CRBSI with DefenCath
Dec 18 2025
Globenewswire
FDA Approves Fast Track Status for ADAG's Colorectal Cancer Treatment
Dec 17 2025
NASDAQ.COM
5 Top Value Stocks with High Earnings Yields Before Important Economic Reports
Dec 16 2025
NASDAQ.COM
CRMD Surges Over 40% Year-to-Date: Should You Buy, Sell, or Hold?
Dec 11 2025
NASDAQ.COM
Show More News
